NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Voltar para busca
Dado oficial do USPTO
TT T-THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
07/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 42, 44
Data de depósito
12/07/2023
Data de registro
07/07/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/07/2026
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Cambridge, GB
Examinador
ANDERSON, DANIELLE LYNN
Unidade examinadora
M40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of an abstract design in the color light blue, within which is a white upside down letter "T" on top of a white right side up letter "T", next to which is the word element "T-THERAPEUTICS", the "T" and hyphen being light blue, and the word "THERAPEUTICS" in dark blue.
Titulares e representantes
Titulares
T-Therapeutics Limited
Representantes
Stacy J. Grossman Law Office of Stacy J. Grossman PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; pharmaceutical preparationsin particularchemical and biological preparations for medical purposesfor the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposespharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; immunotherapeutic drugs namelypharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; excluding preparations for RNA-based gene silencing
Classe 9
Downloadable computer software for use in collectinganalyzing and organizing data in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; downloadable computer software for use in collectinganalyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collectinganalyzing and organizing data in the field of antibodies; devices for analyzing genome informationlaboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualizationscientific analysis of genetic sequences; downloadable software for the managinganalysisvisualization of biological data; excluding software and devices for RNA-based gene silencing and hepatocyte-specific computational biology
Classe 42
Scientific and technological servicesscientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infectionscancerdisease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the managementvisualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; excluding services related to RNA-based gene silencing and hepatocyte-specific computational biology
Classe 44
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNAgeneticsgenetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2026
PUBO
PUBLISHED FOR OPPOSITION
19/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/04/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
21/04/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/04/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
21/04/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/04/2026
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
08/10/2025
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
21/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/04/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
20/02/2025
GNSL
LETTER OF SUSPENSION E-MAILED
20/02/2025
CNSL
SUSPENSION LETTER WRITTEN
20/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/01/2025
ALIE
ASSIGNED TO LIE
16/01/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
19/12/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/12/2024
GNSL
LETTER OF SUSPENSION E-MAILED
16/12/2024
CNSL
SUSPENSION LETTER WRITTEN
16/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/10/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2024
GNRT
NON-FINAL ACTION E-MAILED
10/07/2024
CNRT
NON-FINAL ACTION WRITTEN
10/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/05/2024
GRML
CORRESPONDENCE E-MAILED
27/03/2024
CNRT
NON-FINAL ACTION WRITTEN
27/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/03/2024
DOCK
ASSIGNED TO EXAMINER
20/03/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2023
NWAP
NEW APPLICATION ENTERED
15/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TT T-THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.